Source:http://www4.wiwiss.fu-berlin.de/dailymed/resource/drugs/2059
| Predicate | Object |
|---|---|
| rdf:type | |
| rdfs:label |
Maxidex (Ointment)
|
| dailymed-instance:clinicalP... |
Dexamethasone sodium phosphate suppresses the inflammatory response to a variety of agents and it probably delays or slows healing. No generally accepted explanation of these steroid properties has been advanced.
|
| dailymed-instance:activeIng... | |
| dailymed-instance:supply |
In 3.5g ophthalmic tubes. NDC 0065-0616-35<br/>STORAGE: Store at 8��- 27��C (46��to 80��F). CAUTION: Federal (USA) law prohibits dispensing without prescription. ALCON' Ophthalmic Alcon Laboratories, Inc. Fort Worth, Texas 76134
|
| dailymed-instance:activeMoi... | |
| dailymed-instance:inactiveI... | |
| dailymed-instance:genericMe... |
dexamethasone sodium phosphate
|
| dailymed-instance:fullName |
Maxidex (Ointment)
|
| dailymed-instance:adverseRe... |
The following adverse reactions have been reported: glaucoma with optic nerve damage, visual acuity and field defects, posterior subcapsular cataract formation, secondary ocular infections from pathogens including herpes simplex, and perforation of the globe. Rarely, filtering blebs have been reported when topical steroids have been used following cataract surgery. Rarely, stinging or burning may occur.
|
| dailymed-instance:represent... | |
| dailymed-instance:routeOfAd... | |
| dailymed-instance:name |
Maxidex
|